Unmet needs in rheumatoid arthritis
Open Access
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 7 (3) , S2-S8
- https://doi.org/10.1186/ar1736
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trialArthritis & Rheumatism, 2004
- A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateAnnals of the Rheumatic Diseases, 2004
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Economic burden of rheumatoid arthritis: a systematic reviewRheumatology, 2000
- An assessment of the annual and long-term direct costs of rheumatoid arthritis: The impact of poor function and functional declineArthritis & Rheumatism, 1999
- Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three MedicationsNew England Journal of Medicine, 1996
- LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARSThe Lancet, 1987
- Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.1986